Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cochlear ( (AU:COH) ) has issued an announcement.
Cochlear Limited’s 2025 Annual General Meeting highlighted its continued leadership in the implantable hearing solutions industry, emphasizing its commitment to innovation and long-term growth. The company reported significant achievements, including helping over 53,000 individuals with cochlear or acoustic implants, which have been estimated to provide a net societal benefit of over $9 billion. Additionally, a recent study from South Korea underscored the cognitive benefits of cochlear implants over hearing aids, showing a reduced risk of dementia for users with severe to profound hearing loss.
The most recent analyst rating on (AU:COH) stock is a Sell with a A$280.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a global leader in implantable hearing solutions, dedicated to connecting people to a full life of hearing. The company focuses on transforming the understanding and treatment of hearing loss, addressing unmet clinical needs, and advocating for accessibility to hearing solutions.
Average Trading Volume: 135,941
Technical Sentiment Signal: Buy
Current Market Cap: A$18.78B
See more data about COH stock on TipRanks’ Stock Analysis page.